HPV legislation in Arizona

Women in Government Ratings
Women in Government, a non-profit network of state level women legislators, receives significant funding from the pharmaceutical industry, including Merck, GlaxoSmithKline, and Digene Corporation -- all with products related to HPV vaccination and testing. According to their report, "The 'State' of Cervical Cancer Prevention in America - 2008" :

POPULATION: 6,166,318

Incidence & Mortality (2008 Score / 2007 Score)
 * Cervical Cancer Incidence Rate: 7.2/100,000 (2 / 2)
 * Cervical Cancer Incidence Rate/Race: White: 7.0, Black: 5.6
 * Cervical Cancer Mortality Rate: 2.3/100,000 (1 / 1)
 * Cervical Cancer Mortality Rate/Race: White: 2.2, Black: 4.1, Hispanic: 4.9, American Indian/Alaskan: 5.2

Screening (2008 Score / 2007 Score)
 * Cervical Cancer Screening Rate: 84.1% (1 / 1)
 * Cervical Cancer Screening Rate/Race: White: 87.4%, Hispanic: 79.7%, American Indian/Alaskan: 87.5%
 * % Uninsured/Unscreened: 23.4% (1 / 1)
 * Medicaid Coverage HPV Testing: Unrestricted (2 / 2)

Healthcare Access (2008 Score / 2007 Score)
 * Rate Uninsured Women: 22% (0 / 1)
 * % Low Income/Uninsured Women: 40%

Policy Initiatives and Infrastructure (2008 Score / Cumulative Score (2005–2008)

Screening Requirements (0 / 0)
 * There are no new screening requirements.

Task Forces (0 / 1)
 * There is no new cervical cancer prevention task force legislation.

Access to HPV Vaccines (1 /1) Containment System to provide the HPV vaccine for female clients 21–26 years old; did not leave committee.
 * SB 1385 would appropriate $2.9 million to the AZ Healthcare Cost
 * SB 1502 would require insurance providers to cover the HPV vaccine; did not leave committee.

HPV Vaccine Information Programs (1 / 1)
 * SB 1437 would appropriate $200,000 for outreach/education on several vaccines, including HPV vaccine; did not leave committee.

Miscellaneous (0 / 2)
 * There is no new miscellaneous cervical cancer prevention activity.

Annual Ratings
 * 2008: Good (12 out of 22 points)
 * 2007: Good (11 out of 18 points)

SourceWatch Resources

 * Gardasil
 * GlaxoSmithKline
 * Merck
 * Women in Government
 * Edelman
 * The Marketing of Gardasil in Australia
 * The Marketing of Gardasil in Canada
 * The Marketing of Gardasil in Europe
 * The Marketing of Gardasil in New Zealand
 * The Marketing of Gardasil in the United States
 * Direct-to-consumer advertising
 * Disease Mongering
 * Drug industry